No photo of Peter Cole

View Scopus Profile

Peter Cole

  • 1155 Citations
  • 20 h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Peter Cole is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Methotrexate Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Folic Acid Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

1 Citation (Scopus)

Association of Combined Modality Therapy vs Chemotherapy Alone with Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma

Jhawar, S. R., Rivera-Núñez, Z., Drachtman, R., Cole, P., Hoppe, B. S. & Parikh, R., May 1 2019, In : JAMA Oncology. 5, 5, p. 689-695 7 p.

Research output: Contribution to journal › Article

Combined Modality Therapy
Hodgkin Disease
Pediatrics
Drug Therapy
Survival

Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort

Ladas, E. J., Orjuela, M., Stevenson, K., Cole, P., Lin, M., Athale, U. H., Clavell, L. A., Leclerc, J. M., Laverdiere, C., Michon, B., Schorin, M. A., Welch, J. G., Asselin, B. L., Sallan, S. E., Silverman, L. B. & Kelly, K. M., Jan 1 2019, (Accepted/In press) In : Clinical Nutrition.

Research output: Contribution to journal › Article

Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Nutrition Surveys
Pediatrics
Therapeutics

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group

Kelly, K. M., Cole, P., Pei, Q., Bush, R., Roberts, K. B., Hodgson, D. C., McCarten, K. M., Cho, S. Y. & Schwartz, C., Jan 1 2019, In : British Journal of Haematology.

Research output: Contribution to journal › Article

Hodgkin Disease
Positron-Emission Tomography
Confidence Intervals
Recurrence
Radiotherapy
2 Citations (Scopus)

An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001

Kahn, J. M., Cole, P., Blonquist, T. M., Stevenson, K., Jin, Z., Barrera, S., Davila, R., Roberts, E., Neuberg, D. S., Athale, U. H., Clavell, L. A., Laverdiere, C., Leclerc, J. M., Michon, B., Schorin, M. A., Welch, J. J. G., Sallan, S. E., Silverman, L. B. & Kelly, K. M., Mar 1 2018, In : Pediatric Blood and Cancer. 65, 3, e26871.

Research output: Contribution to journal › Article

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Hispanic Americans
Survival
Neoplasms
Disease-Free Survival
6 Citations (Scopus)

Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial

Cole, P., McCarten, K. M., Pei, Q., Spira, M., Metzger, M. L., Drachtman, R., Horton, T. M., Bush, R., Blaney, S. M., Weigel, B. J. & Kelly, K. M., Sep 1 2018, In : The Lancet Oncology. 19, 9, p. 1229-1238 10 p.

Research output: Contribution to journal › Article

gemcitabine
Hodgkin Disease
Young Adult
Pediatrics
Recurrence